Immune Thrombocytopenia Resolved by Eltrombopag in a Carrier of Glucose-6-Phosphate Dehydrogenase Deficiency

Turk J Haematol. 2016 Mar 5;33(1):77-8. doi: 10.4274/tjh.2015.0181.

Authors

Laura Scaramucci, Pasquale Niscola¹, Massimiliano Palombi, Andrea Tendas, Marco Giovannini, Paolo de Fabritiis

Affiliation

¹ Sant'Eugenio Hospital, Clinic of Hematology, Rome, Italy. E-mail: [email protected].

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Benzoates / therapeutic use*
Blood Platelets / drug effects
Elective Surgical Procedures
Female
Glycogen Storage Disease Type I / complications*
Glycogen Storage Disease Type I / genetics
Hemolysis
Heterozygote
Humans
Hydrazines / therapeutic use*
Middle Aged
Platelet Count
Purpura, Thrombocytopenic, Idiopathic / complications
Purpura, Thrombocytopenic, Idiopathic / drug therapy*
Purpura, Thrombocytopenic, Idiopathic / surgery
Pyrazoles / therapeutic use*
Splenectomy

Substances

Benzoates
Hydrazines
Pyrazoles
eltrombopag